Regarding the mechanism, we clarify that EGFR signaling was regulated by GBP2, and also demonstrated that GBP2 directly interacted with KIF22 and regulated glioma progression through KIF22/EGFR signaling. The gene discussed is KIF22; the disease is central nervous system cancer.